Search

Aurobindo Pharma

Sector: Healthcare | Industry: Drugs & Pharma
R 789.55 7.15  | 0.91% 29.54% 19.98 46,102.77
NSE Price: Apr 18, 15:58 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Apr 18, 15:58 789.55 7.15 0.91% 785.00 782.40 1,602,160 779.00 - 794.00
BSE Apr 18, 2019 786.85 3.10 0.40% 783.80 783.75 54,982 778.10 - 792.70
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 2,559,939 P/B: 3.37 NSE Code: AUROPHARMA
52-Week Range: R 527.00 - 830.45 Dividend Yield: 0.32% BSE Code: 524804
TTM EPS: R 39.39 Book Value: R 233.54 Face Value: R 1
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 36
Price Graph
  • Sun Pharmaceutical Inds. (NSE)
  • S&P BSE 100


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 36 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Aurobindo Pharma 7.72 1.57 2.53 29.54 0.29 23.41 42.45
S&P BSE Sensex 8.52 2.74 7.57 14.01 14.88 11.57 13.50
S&P BSE Healthcare 4.00 1.86 4.92 5.42 -2.49 6.62 16.96
Company's return has been calculated on basis of NSE's price.
As on Apr 18, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 10.42 10.75 22.97
Net Profit 5.38 15.48 52.71
EPS 5.28 15.30 52.31
Book Value 24.63 31.19 34.83
Average
Operating Margin 23.53 23.98 24.10
Net Margin 14.61 14.78 14.32
Return on Networth 22.99 27.69 31.03
Return on Investment 22.72 25.00 25.87
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 10.91 21.53 30.14
Operating Profit 13.60 8.65 38.26
Net Profit 16.11 19.32 34.35
EPS 16.48 19.70 34.76
TTM
Revenue 5.37 13.85 11.03
Operating Profit 2.50 -1.43 -3.21
Net Profit 5.25 -4.87 -4.78
EPS 5.35 -4.92 -4.76
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Aurobindo Pharma 46,102.77 18,320.43 2,304.22 12.46 22.99 3.37 19.98
Piramal Enterprises 49,101.44 12,526.73 4,664.20 36.62 23.42 1.79 9.90
Sun Pharmaceutical Inds. 110,873.27 28,879.09 4,014.58 13.42 7.05 2.61 33.45
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Apr 05, 2019 Challa Venkata Rami Reddy  Sell Market 2,500 786.60 19.67
Apr 05, 2019 Godi Bhaskara Reddy  Sell Market 5,000 786.60 39.33
Apr 05, 2019 Kaushalkumar Ashokkumar Prajapati  Sell Market 2,000 786.60 15.73
Apr 05, 2019 KJVenkata Rama Reddy  Sell Market 2,000 786.60 15.73
Apr 05, 2019 Malineni Ventakeswar Rao  Sell Market 2,000 786.60 15.73
Fund Houses invested in the stock
Fund Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
HDFC Mutual Fund 6.070 5.985 6.100 5.976 5.662
SBI Mutual Fund 1.665 1.558 1.356 0.773 0.745
Reliance Mutual Fund 1.581 1.876 1.996 2.265 2.198
Aditya Birla Sun Life Mutual Fund 0.838 0.869 1.363 2.731 2.274
IDFC Mutual Fund 0.763 0.667 0.536 0.462 0.434
ICICI Prudential Mutual Fund 0.461 0.517 0.553 0.591 0.500
DSP Mutual Fund 0.384 0.325 0.264 0.182 0.169
Mirae Asset Mutual Fund 0.279 0.256 0.228 0.242 0.223
UTI Mutual Fund 0.278 0.406 0.443 0.518 0.921
Kotak Mahindra Mutual Fund 0.225 0.469 0.584 0.519 0.543
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Aurobindo Pharma Ltd.

Address: Plot No. 2, Maitrivihar, Ameerpet, Hyderabad, Telangana - 500038 | Phone: +91-040-66725000 | Fax: +91-040-23746833 / 23741080

Email: [email protected]

Website: www.aurobindo.com

Registrar & Transfer Agent: Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

comments powered by Disqus
Essential checks
Altman Z-Score
5.32
Piotroski F-Score
4
Modified C-Score
2
5-Years Price to Earnings
19.98
5-Years Price to Book
3.37
Earnings Yield
EBIT / Enterprise value
6.17%
PEG
Price / Earnings to growth ratio
0.82
Related Stocks
  Current Price   Chng %
Biocon R615.20 -1.17%
Cadila Healthcare R336.50 -0.41%
Cipla R561.55 +0.39%
Divi's Laboratories R1,724.35 +0.57%
Dr. Reddy's Lab R2,799.10 -0.92%
Glaxosmithkline Pharma R1,299.90 +0.02%
Lupin R835.80 +0.34%
Piramal Enterprises R2,649.85 -0.86%
Sun Pharmaceutical Inds. R463.20 +0.14%
Torrent Pharmaceuticals R1,836.60 -0.14%
As on Apr 18, 15:59